Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older
Clinical trial NCT01814826 · COMPLETED
Trial details
- NCT number
- NCT01814826
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-10
- Primary completion
- 2016-05-03
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.